menu
    • menu
    [{"orgOrder":0,"company":"HOPO Therapeutics","sponsor":"BARDA","pharmaFlowCategory":"D","therapeuticArea":"Pharmacology\/Toxicology","country":"","productType":"Small molecule","year":"2024","type":"Funding","leadProduct":"HOPO-101","moa":"","graph1":"Technology","graph2":"Phase I\/II","graph3":"HOPO Therapeutics","amount2":0.23000000000000001,"highestDevelopmentShortName":"","therapeuticAreaShortName":"Technology","amount2New":0.94999999999999996,"dosageForm":"","sponsorNew":"HOPO Therapeutics \/ BARDA","highestDevelopmentStatusID":"14","companyTruncated":"HOPO Therapeutics \/ BARDA"}]

    Find Clinical Drug Pipeline Developments & Deals by HOPO Therapeutics

    Menu

    HOPO Therapeutics

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            HOPO Therapeutics

                            U.S.A arrow
                            BMWS24
                            Not Confirmed

                            HOPO Therapeutics

                            U.S.A arrow
                            BMWS24
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : HOPO-101

                            Therapeutic Area : Pharmacology/Toxicology

                            Study Phase : Phase I

                            Sponsor : BARDA

                            Deal Size : $226.0 million

                            Deal Type : Funding

                            DEALS_DEV arrow-down

                            HOPO Awarded Up to $226 Million from BARDA for Development of its Oral Decorporation Agent

                            Details : The funds will be used to advance development of the drug candidate HOPO-101 as a possible treatment for lead poisoning.

                            Brand Name : HOPO 14-1

                            Molecule Type : Small molecule

                            Upfront Cash : Undisclosed

                            October 28, 2024

                            Lead Product(s) : HOPO-101

                            Therapeutic Area : Pharmacology/Toxicology

                            Highest Development Status : Phase I

                            Sponsor : BARDA

                            Deal Size : $226.0 million

                            Deal Type : Funding

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth